This finding demonstrated that inhibiting KDM1A was sufficient to assist either endogenous T cells or CAR T cells present in the tumor in killing a heterogeneous tumor cell population containing tumor cells completely lacking expression of the target antigen. Here, KDM1A is linked to neoplasm.